2024 |
Surmodics, Inc.
|
Senior Vice President, Finance and Information Technology and Chief Financial Officer |
1.3 M |
3.8 % |
2023 |
Surmodics, Inc.
|
Senior Vice President, Finance and Information Technology and Chief Financial Officer |
1.3 M |
23.9 % |
2022 |
Surmodics, Inc.
|
Senior Vice President, Finance and Information Technology and Chief Financial Officer |
1.0 M |
7.6 % |
2022 |
Surmodics, Inc.
|
- |
1.0 M |
7.6 % |
2021 |
Surmodics, Inc.
|
- |
972.0 K |
9.9 % |
2021 |
Surmodics, Inc.
|
Senior Vice President, Finance and Information Technology and Chief Financial Officer |
972.0 K |
9.9 % |
2021 |
Surmodics, Inc.
|
- |
972.0 K |
9.9 % |
2020 |
Surmodics, Inc.
|
- |
884.4 K |
8.3 % |
2020 |
Surmodics, Inc.
|
- |
884.4 K |
8.3 % |
2020 |
Surmodics, Inc.
|
Senior Vice President, Finance and Information Technology and Chief Financial Officer |
884.4 K |
8.3 % |
2019 |
Surmodics, Inc.
|
- |
816.6 K |
2.2 % |
2019 |
Surmodics, Inc.
|
- |
816.6 K |
2.2 % |
2019 |
Surmodics, Inc.
|
Vice President, Finance and Chief Financial Officer |
816.6 K |
2.2 % |
2018 |
Surmodics, Inc.
|
- |
798.6 K |
- |
2018 |
Surmodics, Inc.
|
Interim Vice President, Finance, Chief Financial Officer and Vice President of Corporate Development and Strategy |
798.6 K |
- |
2018 |
Surmodics, Inc.
|
- |
798.6 K |
- |
2017 |
Surmodics, Inc.
|
Vice President of Corporate Development and Strategy |
- |
- |
2016 |
Surmodics, Inc.
|
Vice President of Corporate Development and Strategy |
- |
- |
2015 |
Surmodics, Inc.
|
Vice President, Corporate Development and Strategy |
- |
- |
2014 |
Surmodics, Inc.
|
Vice President, Corporate Development and Strategy |
- |
- |
2013 |
Surmodics, Inc.
|
Vice President of Corporate Development and Strategy |
604.6 K |
13.9 % |
2012 |
Surmodics, Inc.
|
- |
530.8 K |
62.0 % |
2012 |
Surmodics, Inc.
|
Vice President of Finance and Interim Chief Financial Officer |
530.8 K |
62.0 % |
2011 |
Surmodics, Inc.
|
- |
327.7 K |
- |
2011 |
Surmodics, Inc.
|
- |
327.7 K |
- |
2011 |
Surmodics, Inc.
|
Vice President of Finance and Interim Chief Financial Officer |
327.7 K |
- |
2010 |
Surmodics, Inc.
|
General Manager, In Vitro Diagnostics |
- |
- |